INCOME TAXES	3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]
INCOME TAXES	15. INCOME TAXES In accordance with ASC topic 740, Income Taxes (“ASC 740”), and ASC subtopic 740-270, Income Taxes: Interim Reporting, the income tax provision for the three months ended March 31, 2020 is based on the estimated annual effective tax rate for fiscal year 2020. The estimated effective tax rate may be subject to adjustment in subsequent quarterly periods as the estimates of pretax income for the year, along with other items that may affect the rate, may change and may create a different relationship between domestic and foreign income and loss. Valuation Allowance Recorded for Deferred Tax Assets As of March 31, 2020, a valuation allowance was provided for the U.S., Hong Kong, Mexico, Spain, France, and Brazil where the Company previously determined in prior periods the deferred tax assets will not more likely than not be realized. Evaluation of the remaining jurisdictions as of March 31, 2020, resulted in the determination that no additional valuation allowances were necessary at this time. However, the Company will continue to assess the need for a valuation allowance against its deferred tax assets in the future and the valuation allowance will be adjusted accordingly, which could materially affect the Company’s financial position and results of operations. As of March 31, 2020, and December 31, 2019, the Company’s U.S. deferred tax liability was $2.6 million and $2.5 million, respectively, related to its goodwill and indefinite lived intangibles. As of March 31, 2020 the Company had foreign net deferred tax assets of $0.1 million compared to foreign net deferred tax assets of $0.1 million at December 31, 2019. As of March 31, 2020, and December 31, 2019, the Company had no unrecognized tax benefits. For the three months ended March 31, 2020 the Company recorded an income tax expense of $0.4 million related to profits of operations for foreign jurisdictions in the U.K., Germany, China, France and Canada and deferred tax expense related to the tax impact of amortization of indefinite lived intangible assets.

INCOME TAXES

3 Months Ended

Mar. 31, 2020

15. INCOME TAXES

In accordance with ASC topic 740, Income Taxes (“ASC 740”), and ASC subtopic 740-270, Income Taxes: Interim Reporting, the income tax provision for the three months ended March 31, 2020 is based on the estimated annual effective tax rate for fiscal year 2020. The estimated effective tax rate may be subject to adjustment in subsequent quarterly periods as the estimates of pretax income for the year, along with other items that may affect the rate, may change and may create a different relationship between domestic and foreign income and loss.

Valuation Allowance Recorded for Deferred Tax Assets

As of March 31, 2020, a valuation allowance was provided for the U.S., Hong Kong, Mexico, Spain, France, and Brazil where the Company previously determined in prior periods the deferred tax assets will not more likely than not be realized.

Evaluation of the remaining jurisdictions as of March 31, 2020, resulted in the determination that no additional valuation allowances were necessary at this time. However, the Company will continue to assess the need for a valuation allowance against its deferred tax assets in the future and the valuation allowance will be adjusted accordingly, which could materially affect the Company’s financial position and results of operations.

As of March 31, 2020, and December 31, 2019, the Company’s U.S. deferred tax liability was $2.6 million and $2.5 million, respectively, related to its goodwill and indefinite lived intangibles. As of March 31, 2020 the Company had foreign net deferred tax

assets of $0.1 million compared to foreign net deferred tax assets of $0.1 million at December 31, 2019. As of March 31, 2020, and December 31, 2019, the Company had no unrecognized tax benefits.

For the three months ended March 31, 2020 the Company recorded an income tax expense of $0.4 million related to profits of operations for foreign jurisdictions in the U.K., Germany, China, France and Canada and deferred tax expense related to the tax impact of amortization of indefinite lived intangible assets.